Autoplay Next video from Max length

Midas Letter RAW 51: Cronos Group, Citron Research Short Report, Justin B. Marshall, & Khiron

1,125 views · Published 31 August 2018 · 1:22:38 · Indexed 12 November 2026

Channel: Midas Letter · 2018 · News & Politics

Midas Letter RAW highlights the stocks and stories to watch in the Canadian markets today. James West and Ed Milewski provide comprehensive fundamental & technical analysis on all trending business and investment news, while interviewing the top CEOs of all public companies and analysts with the highest reputations in the business.

14:15 – West Coast correspondent Justin B. Marshall meets with Ryan, an organic cannabis farmer in California, to talk about the strains Ryan grows and his cannabis yields. Ryan shares his thoughts on regulatory issues and counterfeit cannabis oil.  

1:10:35 – Khiron Life Sciences (CVE:KHRN) (OTCMKTS:KHRNF) VP of Compliance and former U.S. Drug Enforcement Administration (DEA) Chief of Pharmaceutical Investigations Matt Murphy shares why the company’s compliance philosophy has advantageous benefits for international expansion.

************************

Check out our website: 
https://MidasLetter.com

************************

SUBSCRIBE to our YouTube: 
http://bit.ly/MidasLetterYoutube 

SUBSCRIBE to our Newsletter:
http://bit.ly/MidasLetterNewsletter 

Download Our Podcast on iTunes:
http://bit.ly/MidasLetterPodcast

************************

Follow Us on Twitter: 
http://bit.ly/MidasLetterTwitter

Like Us on Instagram: 
http://bit.ly/MidasLetterInsta 

Like Us on Facebook: 
http://bit.ly/MidasLetterFacebook

************************

#MidasLetter
#TechnicalAnalysis
#WeedStocks

Midas Letter RAW 51: Cronos Group, Citron Research Short Report, Justin B. Marshall, & Khiron

More from this channel